#post-merger-integration

#post-merger-integration

For pharmaceutical giant Bristol Myers Squibb (BMS), the moment came following its $74 billion acquisition in 2019 of Celgene Corp., when BMS had to fund a major post-merger integration while preparing for the expiration of valuable pharmaceutical patents. Determined to make the most of the opportunity presented by the merger, one of the largest ever in the pharmaceutical industry, BMS leaders have since embarked on an enterprise-wide initiative to modernize departments and improve the use of technology and innovation.

Every company has different internal dynamics and different ways of working, right? says Kariem Abdellatif, the head of Mercator by Citco (Mercator), a specialist entity management provider that helps organizations manage their global entity portfolios, including during complex M&A transactions. So the system you set up has to be able to accommodate those differences, and the entire governance framework for managing entities needs to be flexible enough to handle not just the current complexity, but also future organizational changes.